Identifying and managing heavy menstrual bleeding in primary care
This Research Review E-Learning Module is intended for GPs. It covers the identification, assessment and management of heavy menstrual bleeding (HMB), and is based on a Research Review Educational Series publication entitled “Identifying and managing heavy menstrual bleeding in primary care”.
Before starting the module please read the Research Review Educational Series, accessed through the link below:
to access the quiz source material
Educational Series - Identifying and managing heavy menstrual bleeding in primary care
The PDF through the link above can be viewed on screen, saved and printed.
This E-Learning Module covers:
- Causes and sequelae of HMB
- Identification and assessment of HMB
- Use of the levonorgestrel-releasing intrauterine device (LNG-IUD) for HMB
- Oral treatments for HMB
- Surgical options for HMB
After completing this module, you should have an improved understanding of how to:
- Undertake a systematic clinical assessment of patients with HMB
- Identify patients requiring a pelvic ultrasound and/or endometrial biopsy
- Identify treatment options for HMB available in the primary care setting
- Identify patients with HMB needing referral for specialist care
Expert commentary is provided by:
Dr Gemma Nightingale, a Consultant Obstetrician and Gynaecologist working at Hutt, Boulcott and Bowen Hospitals. Gemma has a special interest in urogynaecology and laparoscopic surgery.
Module questions have been developed by Dr Chris Tofield, who works in primary care skin cancer treatment, is clinical advisor at Bay of Plenty District Health Board, and consultant to Research Review.
“Identifying and managing heavy menstrual bleeding in primary care” E-Learning Module has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 1 CME credit for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes.
This module has been created with an unrestricted grant from Bayer. The content is entirely independent and is based on the published studies and the author’s opinion.